ADLER ERIC (Chief Scientific Officer) sold 0.8% of their position (615.00 shares) of LEXEO THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/20/2025ACC: 0001994972-25-000005
Officer· Chief Scientific Officer
Since Nov 2023
-615.00
Net shares
Net seller
$5.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
615.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−615.00
Price / share
$9.27
Trade value
$5.70K
% of position
0.8%
11/18/2025
73.26K→72.65K
Total
Net shares
−615.00
Net value
-$5.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/18/2025 | S · Sale | −615.00 | $9.27 | $5.70K | 0.8% | 73.26K | 72.65K |
| Total | −615.00 | -$5.70K | ||||||
Derivative Transactions0
No derivative transactions reported